Chronic Obstructive Pulmonary Disease Exacerbation
17
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.8%
2 terminated out of 17 trials
81.8%
-4.7% vs benchmark
18%
3 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin
Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation
Neutrophil to Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Non-invasive Ventilation or CPAP in OSA-COPD Following Admission for an Acute Hypercapnic Respiratory Failure
Muscle Oxygenation in Chronic Obstructive Pulmonary Disease
Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects
The CATALINA Study
Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)
Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2R
Mindfulness-based Interventions in COPD Patients
Improved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients
Comparison of Active Cycle of Breathing Technique and Pursed Lip Breathing With TheraPep
The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation
Acute Exacerbation of COPD and Nebulized Magnesium Sulphate
Volatolom Variation in Severe COPD During Hospitalization for Exacerbation and After Hospitalization (VOC-BPCO-Exa)